Before I delve further into NewsGuard and its underlying agenda, it's important to look at who funds it.
NewsGuard received much of its startup funds from Publicis Groupe, a giant global communications group with divisions that brand imaging, design of digital business platforms, media relations and health care.
Publicis Groupe's health subsidiary, Publicis Health, names Lilly, Abbot, Roche, Amgen, Genentech, Celgene, Gilead, Biogen, Astra Zeneca, Sanofi, Bayer and other Big Pharma giants as clients, which gives you an idea of where its loyalties lie.
GlaxoSmithKline (GSK) has also awarded Publicis Media a healthy piece of business, and the communications group responded by creating a custom "platformGSK" to run the drug giant's media business.
GSK Adds $400 Million to $1.5 Billion Publicis Collaboration
In October 2018, following a five-month review, GSK sent its $1.5 billion media account to Publicis, which beat out other media agencies vying for the account, including Omnicom's PHD and WPP's Group M.1